Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pectointercostal and ESP Block in Open Heart Surgery
NCT05590013Phase 4Unknown
- Sponsor
- Cukurova University
- Start
- Nov 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by Cukurova University. Primary endpoints: Postoperative analgesia (VAS) at 24 hours and Total Morphine Consumption at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05590013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590013.